EUVIMEDEUVIMED entdecken
Crossref

5-HT1A receptor agonist properties of DNA methyltransferase inhibitor decitabine in mice exposed to the forced swim test

Amanda J Sales, Mariana G Fronza, João F Pedrazzi, Sabrina F Lisboa, Francisco S Guimarães

Behavioural Brain Research · 2026-07 · 509 · 116229

DOI: 10.1016/j.bbr.2026.116229 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Behavioural Brain Research, 2026-07. Verfasst von Amanda J Sales und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil. Electronic address: amanda.sal…. Hauptthemen laut MEDLINE: Decitabine, Antidepressive Agents, Receptor, Serotonin, 5-HT1A, Serotonin 5-HT1 Receptor Agonists. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Decitabine is a nucleoside analog that inhibits DNA methyltransferases with therapeutic potential in stress-related disorders, including depression. Serotonin (5-HT) plays a crucial role in stress response and depression through its receptors, especially 5-HT1A receptors (5-HT1AR). Decitabine treatment has shown rapid-acting antidepressant-like effects in different preclinical models, similar to those observed with ketamine. In addition to modulating neuroplastic mechanisms, the antidepressant effects of ketamine have also been associated with serotonergic (5-HT) signaling, including the activation of 5-HT1AR. However, the mechanisms underlying antidepressant action induced by decitabine are still poorly understood. Therefore, this work aimed to investigate the participation of 5-HT in the stress-coping behavior induced by decitabine in the forced swim test (FST), a predictive test of antidepressant effects, by: 1) evaluating if 5-HT1AR antagonism and/or 5-HT depletion would impair decitabine-induced behavioral effects; and 2) analyzing the potential binding of decitabine to 5-HT1AR by molecular docking analysis. Results showed that decitabine (0.2 mg/kg) induced antidepressant-like effects in mice subjected to FST. Pretreatment with WAY100635 (a 5-HT1AR antagonist: 0.1 mg/kg, i.p.), but not PCPA (an inhibitor of 5-HT synthesis: 150 mg/kg, i.p., once per day for 4 days), blocked the effects of decitabine in the FST, indicating the participation of 5-HT1AR independent of 5-HT levels. In silico analysis showed that decitabine exhibits an interaction profile with 5-HT1AR very similar to that of 5-HT, suggesting a direct action of decitabine on these receptors. None of the treatments induced locomotor effects. Our results suggest that the behavioral effect of decitabine in the FST depends on direct activation of 5-HT1AR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DecitabineAntidepressive AgentsReceptor, Serotonin, 5-HT1ASerotonin 5-HT1 Receptor AgonistsBehavior, AnimalStress, PsychologicalDepressionAnimalsMaleMiceSwimmingPyridinesSerotonin 5-HT1 Receptor AntagonistsDisease Models, AnimalPiperazinesSerotoninDNA Modification Methylases

Stichwörter der Autor:innen

DNMT inhibitorDepressionMolecular dockingPCPASerotoninStressWAY100635

Substanzen

DecitabineAntidepressive AgentsReceptor, Serotonin, 5-HT1ASerotonin 5-HT1 Receptor AgonistsPyridinesSerotonin 5-HT1 Receptor AntagonistsN-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamidePiperazinesSerotoninDNA Modification Methylases

Autor:innen und Institutionen

  • Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil. Electronic address: amanda.sales@usp.br.
  • Department of Biomolecular Sciences, School of Pharmaceutical Sciences, University of São Paulo, Ribeirão Preto, Brazil.
  • Department of Neurosciences and Behavioral Sciences, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.
  • Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil. Electronic address: fsguimar@fmrp.usp.br.

Zitieren

APA

Sales, A. J., Fronza, M. G., Pedrazzi, J. F., Lisboa, S. F., & Guimarães, F. S. (2026). 5-HT1A receptor agonist properties of DNA methyltransferase inhibitor decitabine in mice exposed to the forced swim test. Behavioural Brain Research, 509, 116229. https://doi.org/10.1016/j.bbr.2026.116229

Vancouver

Sales AJ, Fronza MG, Pedrazzi JF, Lisboa SF, Guimarães FS. 5-HT1A receptor agonist properties of DNA methyltransferase inhibitor decitabine in mice exposed to the forced swim test. Behavioural Brain Research. 2026;509:116229. doi:10.1016/j.bbr.2026.116229

BibTeX
@article{Sales2026,
  author = {Sales, Amanda J and Fronza, Mariana G and Pedrazzi, João F and Lisboa, Sabrina F and Guimarães, Francisco S},
  title = {5-HT1A receptor agonist properties of DNA methyltransferase inhibitor decitabine in mice exposed to the forced swim test},
  journal = {Behavioural Brain Research},
  year = {2026},
  volume = {509},
  pages = {116229},
  doi = {10.1016/j.bbr.2026.116229}
}
Kostenlos starten →